Image of Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC):
an open-label, randomised, controlled phase 2 trial

LITERATURE

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial


Results of small-scale studies have suggested that stem-cell therapy is safe and effective in patients with
liver cirrhosis, but no adequately powered randomised controlled trials have been done. We assessed the safety and
efficacy of granulocyte colony-stimulating factor (G-CSF) and haemopoietic stem-cell infusions in patients with
liver cirrhosis.


Availability

REQJ95-03Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Lancet Gastroenterol Hepatol 2018; 3: 25–36
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous